An experimental portable device might be able to detect lung cancer from a person's exhaled breath, researchers report. The device contains "nanoflake" sensors that can detect small changes in the ...

Fresenius Medical’s (FMS) heart and lung group has been awarded a national group purchasing ... respiratory failure or acute cardiopulmonary failure. Novalung offers a portable therapy solution ...

Inogen supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to ...

Shanghai Chest Hospital will carry out research into a novel cell therapy for lung cancer next year, with the first eligible patient to be recruited in January. A total of 20 patients are expected ...

Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today announced its heart and lung group has been awarded a national group ...

Optune Lua for concurrent use with PD-1/PD-L1 inhibitors or docetaxel for adult patients with metastatic non-small cell lung cancer (mNSCLC) who have progressed on or after a platinum-based regimen.

A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at . The Company's standard investor presentation is also available through ...